Kaitai Capital

Kaitai Capital is the famous VC, which was founded in 2009. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Hangzhou.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Kaitai Capital, startups are often financed by Viva BioInnovator, TF Capital, Nanjing Jiangbei New District Service Trade Innovation Development Fund. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Xiamen Meiya Wutong Investment Management, Tekla Capital Management. In the next rounds fund is usually obtained by Vertex Ventures China, Source Code Capital, Photon Fund.

The high activity for fund was in 2018. The real fund results show that this VC is 48 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline CARsgen Therapeutics, Amphivena Therapeutics, Tekeluo Biotech For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has exact preference in some founders of portfolio startups.

Besides them, we counted 1 critical employee of this fund in our database.

Notable deals

Review

• No reviews are submitted yet.